Literature DB >> 20130511

Ki-67 quantitative evaluation as a marker of cervical intraepithelial neoplasia and human papillomavirus infection.

Marko Mimica1, Snjezana Tomić, Goran Kardum, Irena Drmić Hofman, Vanja Kaliterna, Lidija Pejković.   

Abstract

OBJECTIVE: To assess the value of Ki-67 quantitative analysis in cervical intraepithelial neoplasia (CIN) in relation to CIN grading and human papillomavirus (HPV) group typing.
METHODS: Cervical samples selected retrospectively from 106 cases were analyzed immunohistochemically for Ki-67-positive nuclei in 3 epithelial layers and by polymerase chain reaction for HPV typing.
RESULTS: The proportion of high-risk HPV positivity was 0% in normal controls and 30% in CIN 1, 57% in CIN 2, and 90% in CIN 3 groups, and there was no low-risk HPV finding in CIN 2 and CIN 3 cases (P < 0.001). High-risk HPV-positive cases exhibited significantly more Ki-67-positive nuclei per 100-mum basal membrane, which were more frequent in the middle and upper third layers of the epithelium compared with low-risk HPV and HPV-negative cases (P < 0.001). The differences among the CIN groups in the total number and in the percentages of Ki-67-positive nuclei in the lower, middle, and upper third layers of the epithelium were significant (P < 0.001). With the cutoff value of more than 33% Ki-67-positive nuclei in the middle and the upper third layers of the epithelium, Ki-67 staining demonstrated 98.4% sensitivity (60/61 cases) and 97.8% specificity (44/45 cases) for the detection of CIN 2/CIN 3 in our study group.
CONCLUSIONS: The Ki-67 immunostaining proved to be predictive for high-risk HPV infection, and it can differentiate reactive lesions from cervical dysplasias. Ki-67 quantitative analysis in 3 epithelial layers is a sensitive and specific method of differentiation between CIN 1 and CIN 2/CIN 3 grades and can be a valuable adjunctive method for more accurate CIN grading.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130511     DOI: 10.1111/IGC.0b013e3181bc8da7

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  7 in total

1.  Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.

Authors:  O M Omran; M AlSheeha
Journal:  Pathol Oncol Res       Date:  2014-06-13       Impact factor: 3.201

2.  Peroxiredoxin 3 is a novel marker for cell proliferation in cervical cancer.

Authors:  Jing-Xia Hu; Qun Gao; Lianqin Li
Journal:  Biomed Rep       Date:  2012-11-29

3.  Is human papillomavirus involved in laryngeal neuroendocrine carcinoma?

Authors:  Gyorgy B Halmos; Tom P van der Laan; Bettien M van Hemel; Frederik G Dikkers; Lorian Slagter-Menkema; Bernard F A M van der Laan; Ed Schuuring
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-15       Impact factor: 2.503

4.  Association Between Passive Smoking and the Risk of Cervical Intraepithelial Neoplasia 1 in Korean Women.

Authors:  Kyung-Jin Min; Jae-Kwan Lee; Kyeong A So; Mi Kyung Kim
Journal:  J Epidemiol       Date:  2017-10-25       Impact factor: 3.211

5.  A comparative analysis of clinical and molecular factors with the stage of cervical cancer in a Brazilian cohort.

Authors:  Sergio M Amaro-Filho; Jonathan E Golub; Gerard J Nuovo; Cynthia B Cunha; José E Levi; Luisa L Villa; Cecília V Andrade; Fabio B Russomano; Aparecida Tristão; Andrea Pires; Alcina F Nicol
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

6.  Increased nuclear β-catenin expression in oral potentially malignant lesions: A marker of epithelial dysplasia.

Authors:  Montserrat Reyes; Gonzalo Rojas-Alcayaga; Andrea Maturana; Juan-Pablo Aitken; Carolina Rojas; Ana-Verónica Ortega
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-09-01

7.  Association of Combined Tobacco Smoking and Oral Contraceptive Use With Cervical Intraepithelial Neoplasia 2 or 3 in Korean Women.

Authors:  Hea Young Oh; Mi Kyung Kim; Sang-Soo Seo; Jae-Kwan Lee
Journal:  J Epidemiol       Date:  2015-10-03       Impact factor: 3.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.